Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity. A multicenter randomized controlled trial.
Ruban A, Miras AD, Glaysher M, Goldstone AP, Prechtl CG, Johnson N et al.
Ann Surg 2022; 275: 440-447.
The liner was used for 12 months in this study that included 170 adults with diabetes. Use of the liner reduced glycated haemoglobin by >20 per cent in 54.6 per cent compared to 55.2 per cent in controls (P=0.85).
Comment: Although the liner did have some positive benefits, it failed to improve glycaemic control.
2 May 2022Read paper
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.